Veracyte (VCYT) Q2 Earnings and Revenues Beat Estimates

Veracyte (VCYT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of a loss of$ 0.03 per share. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1,100%. A quarter ago, it was expected that this molecular diagnostic company would post a loss of$ 0.19 per share when it actually produced a loss of $0.02, delivering a surprise of 89.47%. Over the last four quar ...